Scientists discover a way to kill off tumors in cancer treatment breakthrough

April 5, 2011, Queen's University Belfast

Scientists from the School of Pharmacy at Queen's University Belfast and Almac Discovery Ltd have developed a new treatment for cancer which rather than attacking tumours directly, prevents the growth of new blood vessels in tumours, starving them of oxygen and nutrients, thereby preventing their growth.

Targeting tumour is not a new concept, however, this drug attacks the blood vessels using an entirely different pathway and therefore could be useful for treating tumours which don't respond to or which are resistant to current therapies of this type.

Professor Tracy Robson and her research team at Queen's, in collaboration with researchers at Almac Discovery, developed a new drug to disrupt the tumour blood supply. They have demonstrated that this leads to highly effective inhibition of tumour growth in a number of models as reported this month in , a journal of the American Association for Cancer Research. Almac Discovery is developing the and expects to start clinical trials within the next year.

Professor Tracy Robson from the School of Pharmacy at Queen's explains: "By understanding the anti-angiogenic potential of the natural protein, FKBPL, we have been able to develop small peptide-based drugs that could be delivered to prevent tumour growth by cutting off their blood supply. This is highly effective in models of prostate and .

"However, this also has the potential for the treatment of any solid tumour and we're excited about continuing to work with Almac Discovery as this drug enters clinical trials."

Dr Stephen Barr, President and Managing Director of Almac Discovery said: "This is a first class example of a collaboration between a university and industry to produce a novel approach to that has a real chance of helping patients".

The Almac Discovery / Queen's University drug is currently undergoing preclinical development and may provide a first-in-class therapy for targeting tumour angiogenesis by an entirely different pathway to those agents currently approved.

Related Stories

Recommended for you

New therapeutic gel shows promise against cancerous tumors

February 21, 2018
Scientists at the UNC School of Medicine and NC State have created an injectable gel-like scaffold that can hold combination chemo-immunotherapeutic drugs and deliver them locally to tumors in a sequential manner. The results ...

Five novel genetic changes linked to pancreatic cancer risk

February 21, 2018
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other ...

Kinase inhibitor larotrectinib shows durable anti-tumor abilities

February 21, 2018
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses. All patients had tumors ...

Research could change how doctors treat leukemia and other cancers fed by fat

February 21, 2018
Obesity and cancer risk have a mysterious relationship, with obesity increasing the risk for 13 types of cancer. For some cancers—including pediatric cancers—obesity affects survival rates, which are lower for people ...

New technique predicts gene resistance to cancer treatments

February 21, 2018
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.

Similarities found in cancer initiation in kidney, liver, stomach, pancreas

February 21, 2018
Recent research at Washington University School of Medicine in St. Louis demonstrated that mature cells in the stomach sometimes revert back to behaving like rapidly dividing stem cells. Now, the researchers have found that ...

7 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

nanotech_republika_pl
not rated yet Apr 05, 2011
But cutting the blood supply from the tissue where the cancer grows, you are killing, first of all, the fibroblasts, not the cancer cells, so you're killing the patient body that way. There was a story on this website short time ago.
Jaeherys
not rated yet Apr 05, 2011
By cutting off the blood supply the tumour would die as well would it not? But it does sound like it only reduces the blood flow to the tomour.

They have demonstrated that this leads to highly effective inhibition of tumour growth in a number of models


fuviss_co_uk
5 / 5 (1) Apr 05, 2011
Every day we're closer to extermination of cancer

Good news
jtdrexel
not rated yet Apr 05, 2011
I take it that this drug would be administered directly to the cancerous tissue? Or is the drug a targeted molecule to the cancerous tissue?
MattyC1989
not rated yet Apr 06, 2011
By cutting off the blood flow, or antiangiogenic therapy you essentially cut the nutrients off to the cancerous growth. Kind of like cutting the roots off a plant. Yes, you will kill existing parts of the body that aren't considered cancerous but in very small amounts; furthermore, the alternatives such as chemotherapy or radiation also kill areas of the body in which aren't cancerous. The anti-angiogenic therapy is a far less detrimental way of handling treatment in my opinion.
gwargh
1 / 5 (1) Apr 12, 2011
Plenty of misunderstanding here... Tumors don't spread or grow if they're unable to grow, so angiogenesis (creation of NEW blood vessels) is critical in cancers metastasizing. This drug aims to prevent creation of new blood vessels, so it's a great treatment for anyone who isn't recovering from serious injuries or actively growing. It should not kill of any of the surrounding tissue.
nanotech_republika_pl
not rated yet Apr 16, 2011
qwargh, argue with this news
http://www.physor...643.html
"...the researchers say their new theory of stromal metabolic re-programming suggests that cancer cells do not need blood vessels to feed them, which explains why some angiogensis inhibitors (drugs that shut down blood vessel growth) have not worked - and, in fact, may be dangerous."

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.